THC and CBD produced opposite effects on brain activation in the striatum, hippocampus, amygdala, and cortex across four tasks, and CBD pretreatment prevented THC-induced psychotic symptoms.
Read this if you want to understand why THC and CBD have such different effects and whether CBD can protect against THC-related psychosis.
Opposite brain effects across 5 brain regions and 4 tasks; CBD blocked THC-induced psychosis
The Backstory
Cannabis users have known this intuitively for decades: strains high in CBD feel different from strains with THC only. Less paranoia. Less cognitive fog. A calmer kind of engagement. Budtenders describe it as CBD "smoothing out" the THC experience.
In 2010, a team at King's College London decided to look at this claim with one of the most powerful tools in neuroscience — functional MRI. They gave healthy volunteers either THC, CBD, or placebo, then slid them into a brain scanner and watched what happened while they performed cognitive tasks.
What they saw was striking: THC and CBD didn't just have different effects on the brain. They had opposite effects. Region by region, task by task, where one compound turned brain activity up, the other turned it down.
Then they went one step further. They gave people CBD before injecting them with THC — and the CBD blocked the psychotic symptoms THC normally produces.
The Experiment
Fifteen healthy men with minimal prior cannabis exposure were scanned three times, each time after receiving one of three oral preparations: 10mg of THC, 600mg of CBD, or placebo. They performed four tasks in the scanner: verbal recall, response inhibition (go/no-go), viewing fearful faces, and listening to speech. The within-subject crossover design meant each person served as his own control — the most powerful way to detect differential drug effects.
THC (10mg oral)
- Increased anxiety in most subjects
- Disrupted verbal memory encoding in the hippocampus
- Increased amygdala activation to fearful faces (heightened threat response)
- Altered striatal activation during recall (reward circuit disruption)
- Induced psychotic-like symptoms in some participants
Disrupts
CBD (600mg oral)
- Reduced anxiety below placebo levels in some subjects
- Did not impair memory — preserved hippocampal function
- Attenuated amygdala activation (dampened threat response)
- Opposite striatal activation pattern from THC
- No psychotic-like symptoms — actually reduced baseline psychotic-like experiences
Protects
Bhattacharyya et al. (2010), Neuropsychopharmacology 35(3):764-74
Five Regions, Five Opposites
The fMRI data revealed opposite activation patterns in five distinct brain regions:
The pattern was remarkably consistent: where THC increased activation, CBD decreased it. Where THC disrupted connectivity, CBD preserved it. These weren't random differences — they were mirror images.
CBD Blocks THC-Induced Psychosis
The second experiment was smaller (six volunteers) but more dramatic. Participants received intravenous THC — a route that produces rapid, intense psychoactive effects — on two occasions. Once after placebo pretreatment, once after CBD pretreatment.
Blocked
CBD pretreatment prevented the acute psychotic symptoms normally induced by intravenous THC. Participants who received CBD before THC did not develop the paranoia, perceptual distortions, and disorganized thinking that THC alone reliably produces.
This was a proof-of-concept experiment with only 6 subjects, so it should be interpreted cautiously. But the finding was clear and consistent: CBD actively counteracted THC's psychotogenic effects, not just passively failing to produce them.
Bhattacharyya et al. (2010), Neuropsychopharmacology
This second experiment transformed the study from an interesting observation about brain activation patterns into a finding with direct clinical implications. If CBD can block THC's psychotogenic effects, then the ratio of THC to CBD in a cannabis product isn't just a matter of preference — it's a matter of psychiatric safety.
Why the Ratio Matters
Product Composition
The THC:CBD Ratio Problem
Historical cannabis
Before selective breeding for potency, cannabis typically contained roughly equal amounts of THC and CBD (1:1 to 2:1 ratios). CBD was a natural pharmacological buffer.
Modern high-potency flower
Selectively bred for maximum THC (25-30%), with CBD bred out to near-zero. The natural buffer has been removed.
Concentrates and vapes
70-90% THC with essentially no CBD. The most extreme version of the problem — pure THC with no pharmacological counterbalance.
The Bhattacharyya implication
If CBD produces literally opposite brain effects from THC and can block THC-induced psychosis, then removing CBD from cannabis products may be removing a built-in safety mechanism.
Bhattacharyya et al. (2010); ElSohly et al. (2016)
This study provides the neuroscience backbone for what the Di Forti epidemiological study later confirmed at the population level: high-potency, CBD-absent cannabis is associated with more psychiatric harm than whole-plant cannabis containing both compounds. The market trend toward ever-higher THC with zero CBD isn't just chasing a stronger high — it's removing the molecule that may protect against THC's most dangerous effect.
The Research Team
This study came from one of the world's leading cannabis-brain research groups at King's College London, led by Philip McGuire and Robin Murray. The same team later produced the Leweke antipsychotic trial showing CBD matched a standard antipsychotic in treating schizophrenia, and the McGuire Phase II trial confirming CBD's antipsychotic properties in 88 patients.
Sagnik Bhattacharyya, the lead author, has built his career on understanding how cannabinoids affect the brain. His work represents the most systematic fMRI investigation of THC and CBD ever conducted.
“These findings suggest that the two main ingredients of cannabis have distinct effects on brain function and that the effects of cannabis on brain function may depend on the ratio of these two compounds.”
— Sagnik Bhattacharyya
King's College London, Institute of Psychiatry
From the original 2010 paper — understated in the way that good science often is
The Limitations
The study was small — 15 men in the main experiment, 6 in the second. Only healthy men with minimal cannabis experience were tested. Single oral doses were used, while real-world cannabis use involves repeated exposure through inhalation. The fMRI methodology captures blood-flow correlates of neural activity, not neural activity directly.
These are standard limitations for early-phase human neuroimaging studies, and the within-subject crossover design partially compensates by giving each participant high statistical power. The finding has been broadly replicated in subsequent studies using different tasks and larger samples, though the literature continues to evolve.
Myth vs. Reality
THC and CBD are basically the same thing — they're both just cannabis compounds.
THC and CBD have fundamentally opposite effects on the brain. In regions governing memory, threat processing, and psychosis, they produce mirror-image activation patterns. CBD can actively block THC-induced psychosis. They are as different as a stimulant and a sedative — two molecules with opposing pharmacological profiles that happen to come from the same plant.
The Evidence
fMRI data showing opposite activation in five brain regions (striatum, hippocampus, amygdala, temporal cortex, occipital cortex). CBD pretreatment blocked THC-induced psychotic symptoms. Clinical trials later confirmed CBD's antipsychotic properties (Leweke 2012, McGuire 2018).
Bhattacharyya et al. (2010), Neuropsychopharmacology; Leweke et al. (2012); McGuire et al. (2018)
Related Research
THC vs CBD: The Pharmacological Divide
This fMRI study provides the brain-level evidence for a divide that runs through all of cannabis pharmacology — two molecules with opposing effects sharing the same plant.
CBD as an antipsychotic
Leweke et al. (2012)
CBD matched amisulpride for treating schizophrenia — the clinical translation of Bhattacharyya's finding that CBD counteracts THC's psychotogenic effects
Taming THC: the entourage effect
Russo (2011)
Russo's review making the case that CBD modulates THC's effects — this study is the neuroscience evidence he drew on
High-potency cannabis and psychosis across Europe
Di Forti et al. (2019)
The epidemiological confirmation: cities with high-potency, CBD-absent cannabis markets have more psychosis
THC potency has been rising for decades
ElSohly et al. (2016)
Documents the market trend that made this study urgent — THC rising while CBD disappears from commercial cannabis
If THC and CBD have opposite effects, why does cannabis containing both still get you high?
CBD doesn't block the psychoactive high from THC — it modulates it. In this study, CBD attenuated THC's effects on anxiety, paranoia, and psychotic-like symptoms, but didn't eliminate the subjective feeling of intoxication. Think of CBD as adjusting the character of the high rather than preventing it: less paranoid, less memory-impairing, less likely to trigger psychotic symptoms, but still psychoactive. This is why many users report that cannabis with balanced THC:CBD ratios produces a more manageable, less anxious experience.
Should I take CBD before using THC?
The second experiment in this study suggests CBD pretreatment can prevent THC-induced psychotic symptoms. However, this was tested with IV THC and oral CBD in a controlled lab setting — very different from real-world cannabis use. Some users do take CBD before or alongside THC and report reduced anxiety and paranoia. The pharmacological rationale is sound, but optimal timing and dosing for real-world use haven't been established in clinical trials. Using cannabis products that naturally contain both THC and CBD (balanced strains, full-spectrum products) may be a simpler approach to the same goal.
Does this mean high-THC, zero-CBD products are dangerous?
"Dangerous" is too strong, but this study suggests they carry more psychiatric risk than products containing both cannabinoids. The removal of CBD from modern high-potency cannabis removes a molecule that has demonstrable protective effects against THC's psychotogenic and anxiogenic actions. For most healthy adults, this difference may not matter much. For those with genetic vulnerability to psychosis, it could matter a lot. The Di Forti study showed that the dominance of high-potency cannabis in certain markets was associated with higher psychosis incidence.
What the researchers found
In a two-part study, 15 healthy men completed four tasks during fMRI after receiving THC (10 mg), CBD (600 mg), or placebo.
THC and CBD had opposite effects on brain activation across all four tasks:
- In the striatum during verbal recall
- In the hippocampus during response inhibition
- In the amygdala while viewing fearful faces
- In the superior temporal cortex during speech processing
- In the occipital cortex during visual processing
In a second experiment with 6 volunteers, CBD pretreatment prevented the acute psychotic symptoms normally induced by intravenous THC.
This demonstrated that the two main cannabis compounds have fundamentally opposing brain effects, and that CBD can actively block THC-induced psychosis.
Why it matters
This landmark study demonstrated that THC and CBD have opposing brain effects across multiple cognitive domains and that CBD can prevent THC-induced psychosis, with major implications for cannabis product composition and potential therapeutic applications.
The numbers in context
15 men in fMRI experiment. 6 men in CBD-blocks-psychosis experiment. THC: 10 mg oral. CBD: 600 mg oral. Opposite effects documented in striatum, hippocampus, amygdala, temporal cortex, and occipital cortex.
How the study worked
Two experiments. Experiment 1: Double-blind, placebo-controlled crossover with 15 healthy men receiving oral THC (10 mg), CBD (600 mg), or placebo before fMRI during verbal memory, response inhibition, sensory processing, and emotional processing tasks. Experiment 2: 6 volunteers received IV THC after CBD or placebo pretreatment.
What this study cannot tell us
Small samples (15 and 6). Only healthy men with minimal cannabis experience. Single doses only. The second experiment (CBD blocking THC psychosis) had only 6 participants. IV THC has different kinetics than smoked cannabis.
How to read the evidence
Well-designed crossover fMRI RCT from a leading research group. Small samples but consistent opposing effects across multiple tasks strengthen the finding.
When this study was published
Published in 2010. This study became one of the most cited in cannabinoid neuroscience and has been supported by subsequent larger studies.
The bigger picture
This study provided some of the strongest evidence that cannabis plant composition matters enormously. High-THC strains with minimal CBD may carry greater psychosis risk, while balanced THC:CBD products may be safer and have different clinical profiles.
Questions still open
- What CBD:THC ratio optimally prevents psychotic symptoms? Do the opposing effects persist with chronic use? Could CBD be used clinically to treat cannabis-induced psychosis?
Common questions
Can CBD prevent THC psychosis?
Does this mean CBD is always protective?
Read the original research
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35(3), 764-74
Citation
Bhattacharyya, Sagnik; Morrison, Paul D; Fusar-Poli, Paolo; Martin-Santos, Rocio; Borgwardt, Stefan; Winton-Brown, Toby; Nosarti, Chiara; O' Carroll, Colin M; Seal, Marc; Allen, Paul; Mehta, Mitul A; Stone, James M; Tunstall, Nigel; Giampietro, Vincent; Kapur, Shitij; Murray, Robin M; Zuardi, Antonio W; Crippa, José A; Atakan, Zerrin; McGuire, Philip K. (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35(3), 764-74. https://doi.org/10.1038/npp.2009.184
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)